Dr. Ramasamy earned her PhD in Clinical Medicine Research Programme (specialisation: human embryonic stem cell research) from the Department of Surgery and Cancer, Hammersmith Hospital, Imperial College London, UK. She is heading the Stem Cell Biology Laboratory, Department of Molecular Medicine, a research group focussing on Regenerative Medicine, Stem Cell Technology and Cancer Stem Cell research. Her passion for developing and driving industrial partnerships has steered to a number of successful MOAs and collaborative endeavours through her management of, including, Cell & Molecular Biology Laboratory (CMBL), Central Research Laboratories (CRL) Faculty of Medicine (FOM). During her leadership role as head of the Internationalisation Unit, FOM (IUFOM), many collaborative and networking activities were embarked at the national and international arena paving the path towards excellence in the research and academic portfolio of the faculty and university. She also has been serving the Industrial and Community Engagement (UMICE) portfolio as the chief liaison officer for FOM.

Dr. Ramasamy has been actively engaged in stem cell research for more than a decade now and recently embarked on cancer stem cell research, the research field that she has so much passion. Her research group has set their focus to strive for innovative and creative cutting edge research in developing effective stem cell therapy and target cancer stem cells by developing scientific programs of exceptional merit in collaboration with multiple institutions and industries at national and international levels. She has been leading and involved in many research programmes/grants at national and international levels. She has been invited to present the research findings in many national and international meetings as keynote and invited speaker. Her passion for bringing the impact of regenerative research in Malaysia to a great height is very much evident through her leadership role as the President of Tissue Engineering and Regenerative Medicine Society of Malaysia (TESMA) [2015-2019], Advisory Committee for Tissue Engineering and Regenerative Medicine International Society (TERMIS) World Congress 2021 and many other national and international meetings. As the founding advisor of the Malaysian Society for Extracellular Vesicles (MySEV) and Co-founder of the Innovation Forum-Kuala Lumpur (IFKL) Chapter, she is aspired to build the network with international institutions and societies. Collaborative Intelligence is what Dr. Ramasamy firmly believed in.